NASDAQ:TBPH

Theravance Biopharma News Headlines

$17.56
+0.04 (+0.23 %)
(As of 06/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$16.38
$17.76
50-Day Range
$16.50
$22.46
52-Week Range
$14.48
$22.99
Volume385,114 shs
Average Volume318,060 shs
Market Capitalization$1.15 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.9

Theravance Biopharma (NASDAQ TBPH) News Headlines Today

SourceHeadline
Theravance Biopharma (NASDAQ:TBPH) Shares Gap Down to $17.52Theravance Biopharma (NASDAQ:TBPH) Shares Gap Down to $17.52
americanbankingnews.com - June 21 at 12:00 PM
Theravance Biopharmas Study of Covid-19-Related Lung Injury Drug Didnt Meet Primary EndpointTheravance Biopharma's Study of Covid-19-Related Lung Injury Drug Didn't Meet Primary Endpoint
marketwatch.com - June 21 at 8:10 AM
Theravance Phase 2 Nezulcitinib Study Did Not Meet Primary Goal In Acute Lung Injury Due To COVID-19Theravance Phase 2 Nezulcitinib Study Did Not Meet Primary Goal In Acute Lung Injury Due To COVID-19
markets.businessinsider.com - June 21 at 8:10 AM
Theravance Plunges As Candidate For Covid-Related Lung Injury FailsTheravance Plunges As Candidate For Covid-Related Lung Injury Fails
finance.yahoo.com - June 21 at 8:10 AM
Theravance Biopharma, Inc. Announces Top-Line Results From Phase 2 Study of Nezulcitinib In Patients Hospitalized With Acute Lung Injury Due to COVID-19Theravance Biopharma, Inc. Announces Top-Line Results From Phase 2 Study of Nezulcitinib In Patients Hospitalized With Acute Lung Injury Due to COVID-19
finance.yahoo.com - June 21 at 8:10 AM
Theravance Bio (TBPH) Down 13% Since Last Earnings Report: Can It Rebound?Theravance Bio (TBPH) Down 13% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - June 3 at 1:48 PM
Theravance Biopharma (NASDAQ:TBPH) vs. Paratek Pharmaceuticals (NASDAQ:PRTK) Head to Head ReviewTheravance Biopharma (NASDAQ:TBPH) vs. Paratek Pharmaceuticals (NASDAQ:PRTK) Head to Head Review
americanbankingnews.com - June 1 at 1:06 AM
Theravance Biopharma, Inc. (NASDAQ:TBPH) Analysts Just Slashed This Years EstimatesTheravance Biopharma, Inc. (NASDAQ:TBPH) Analysts Just Slashed This Year's Estimates
finance.yahoo.com - May 9 at 2:08 PM
Theravance (TBPH) Q1 Earnings Lag Estimates, Pipeline on TrackTheravance (TBPH) Q1 Earnings Lag Estimates, Pipeline on Track
finance.yahoo.com - May 5 at 4:59 PM
Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue EstimatesTheravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 4 at 11:07 PM
Theravance Biopharma: Q1 Earnings InsightsTheravance Biopharma: Q1 Earnings Insights
benzinga.com - May 4 at 6:07 PM
BRIEF-Theravance Biopharma Q1 Loss Per Share $1.24BRIEF-Theravance Biopharma Q1 Loss Per Share $1.24
msn.com - May 4 at 6:07 PM
Theravance Biopharma, Inc. Reports First Quarter 2021 Financial Results and Provides Business UpdateTheravance Biopharma, Inc. Reports First Quarter 2021 Financial Results and Provides Business Update
finance.yahoo.com - May 4 at 6:07 PM
Increases to Theravance Biopharma, Inc.s (NASDAQ:TBPH) CEO Compensation Might Cool off for nowIncreases to Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Compensation Might Cool off for now
finance.yahoo.com - April 21 at 9:28 AM
Theravance Biopharma to Report First Quarter 2021 Financial Results on May 4, 2021Theravance Biopharma to Report First Quarter 2021 Financial Results on May 4, 2021
finance.yahoo.com - April 20 at 7:26 AM
Theravance Bio (TBPH) Up 10.1% Since Last Earnings Report: Can It Continue?Theravance Bio (TBPH) Up 10.1% Since Last Earnings Report: Can It Continue?
finance.yahoo.com - March 25 at 1:41 PM
Are Theravance Biopharma, Inc. (NASDAQ:TBPH) Investors Paying Above The Intrinsic Value?Are Theravance Biopharma, Inc. (NASDAQ:TBPH) Investors Paying Above The Intrinsic Value?
finance.yahoo.com - March 4 at 12:25 PM
Theravance Biopharma to Participate in an Upcoming Investor ConferenceTheravance Biopharma to Participate in an Upcoming Investor Conference
finance.yahoo.com - March 2 at 8:36 AM
Theravance Biopharma, Inc. 2020 Q4 - Results - Earnings Call PresentationTheravance Biopharma, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 26 at 5:31 PM
Theravance Biopharma EPS beats by $0.10, misses on revenueTheravance Biopharma EPS beats by $0.10, misses on revenue
seekingalpha.com - February 25 at 4:44 AM
Theravance (TBPH) Q4 Earnings Top Estimates, Revenues In LineTheravance (TBPH) Q4 Earnings Top Estimates, Revenues In Line
nasdaq.com - February 24 at 1:43 PM
Theravance Biopharma: Q4 Earnings InsightsTheravance Biopharma: Q4 Earnings Insights
finance.yahoo.com - February 24 at 12:33 AM
Theravance Biopharma Earnings PreviewTheravance Biopharma Earnings Preview
finance.yahoo.com - February 22 at 6:05 PM
Retrotope Appoints Rick E Winningham as Chairman of Board of Directors in Advance of Key Clinical Trial Data ReadoutsRetrotope Appoints Rick E Winningham as Chairman of Board of Directors in Advance of Key Clinical Trial Data Readouts
marketwatch.com - February 11 at 8:26 AM
Theravance Biopharma to Participate in Upcoming Investor ConferencesTheravance Biopharma to Participate in Upcoming Investor Conferences
finance.yahoo.com - February 10 at 7:03 AM
Theravance Biopharma to Report Fourth Quarter and Full Year 2020 Financial Results on February 23, 2021Theravance Biopharma to Report Fourth Quarter and Full Year 2020 Financial Results on February 23, 2021
finance.yahoo.com - February 9 at 7:32 AM
Is TBPH A Good Stock To Buy According To Hedge Funds?Is TBPH A Good Stock To Buy According To Hedge Funds?
finance.yahoo.com - December 19 at 5:40 PM
Dont Ignore The Fact That This Insider Just Sold Some Shares In Theravance Biopharma, Inc. (NASDAQ:TBPH)Don't Ignore The Fact That This Insider Just Sold Some Shares In Theravance Biopharma, Inc. (NASDAQ:TBPH)
nasdaq.com - December 18 at 3:24 PM
Theravance Bio (TBPH) Down 12.5% Since Last Earnings Report: Can It Rebound?Theravance Bio (TBPH) Down 12.5% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - December 5 at 5:57 PM
Theravance Biopharma Is A BuyTheravance Biopharma Is A Buy
seekingalpha.com - December 2 at 1:26 PM
Theravance Biopharma to Present at the 3rd Annual Evercore ISI HEALTHCONx ConferenceTheravance Biopharma to Present at the 3rd Annual Evercore ISI HEALTHCONx Conference
finance.yahoo.com - November 17 at 8:52 AM
Earnings Update: Theravance Biopharma, Inc. (NASDAQ:TBPH) Just Reported And Analysts Are Trimming Their ForecastsEarnings Update: Theravance Biopharma, Inc. (NASDAQ:TBPH) Just Reported And Analysts Are Trimming Their Forecasts
nasdaq.com - November 9 at 8:04 PM
Analysts Have Lowered Expectations For Theravance Biopharma, Inc. (NASDAQ:TBPH) After Its Latest ResultsAnalysts Have Lowered Expectations For Theravance Biopharma, Inc. (NASDAQ:TBPH) After Its Latest Results
finance.yahoo.com - November 9 at 3:03 PM
Theravance (TBPH) Drops on Q3 Earnings Miss, Revenues In LineTheravance (TBPH) Drops on Q3 Earnings Miss, Revenues In Line
finance.yahoo.com - November 9 at 3:03 PM
Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q3 2020 Results - Earnings Call TranscriptTheravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 6:11 PM
Theravance Biopharma Inc (TBPH) Q3 2020 Earnings Call TranscriptTheravance Biopharma Inc (TBPH) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 7 at 9:37 AM
Theravance Biopharma EPS misses by $0.15, misses on revenueTheravance Biopharma EPS misses by $0.15, misses on revenue
seekingalpha.com - November 5 at 8:17 PM
Theravance Biopharma, Inc. to Host Earnings CallTheravance Biopharma, Inc. to Host Earnings Call
finance.yahoo.com - November 5 at 8:17 PM
Theravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue EstimatesTheravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 5 at 8:17 PM
Innoviva: Only For Short-Term TradersInnoviva: Only For Short-Term Traders
seekingalpha.com - November 4 at 5:03 PM
Theravance Biopharma (TBPH) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseTheravance Biopharma (TBPH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - October 29 at 5:22 PM
Would Shareholders Who Purchased Theravance Biopharma's (NASDAQ:TBPH) Stock Three Years Be Happy With The Share price Today?Would Shareholders Who Purchased Theravance Biopharma's (NASDAQ:TBPH) Stock Three Years Be Happy With The Share price Today?
finance.yahoo.com - October 27 at 5:34 PM
Theravance Biopharma IncTheravance Biopharma Inc
bloomberg.com - October 23 at 5:36 PM
Theravance Biopharma to Report Third Quarter 2020 Financial Results on November 5, 2020Theravance Biopharma to Report Third Quarter 2020 Financial Results on November 5, 2020
finance.yahoo.com - October 22 at 10:03 AM
Hedge Funds Have Never Been This Bullish On Theravance Biopharma Inc (TBPH)Hedge Funds Have Never Been This Bullish On Theravance Biopharma Inc (TBPH)
finance.yahoo.com - October 19 at 1:20 PM
Theravance Biopharma Inc When Issued OverweightTheravance Biopharma Inc When Issued Overweight
markets.businessinsider.com - October 15 at 8:35 PM
Theravance Biopharma Inc When Issued OverweightTheravance Biopharma Inc When Issued Overweight
markets.businessinsider.com - October 15 at 8:35 PM
Theravance Biopharma upgraded by Morgan Stanley following pullbackTheravance Biopharma upgraded by Morgan Stanley following pullback
seekingalpha.com - October 14 at 5:28 PM
Dont Bet On Thervances COVID-19 DrugDon't Bet On Thervance's COVID-19 Drug
seekingalpha.com - October 5 at 2:38 PM
Why Is Theravance Bio (TBPH) Down 17.7% Since Last Earnings Report?Why Is Theravance Bio (TBPH) Down 17.7% Since Last Earnings Report?
finance.yahoo.com - September 5 at 12:45 PM
This page was last updated on 6/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.